English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Daniel Daw | Jan 6, 2016

Proteasomes may open doors to neurodegenerative treatment potential

+ Regulatory
Daniel Daw | Jan 6, 2016

FDA welcomes participation at drug development meetings

+ Technology/Innovation
Jamie Barrand | Jan 6, 2016

Penn State researchers discover possible new therapies for Rett Syndrome

+ Regulatory
Jamie Barrand | Jan 6, 2016

2015 brings changes, improvements for family medicine providers

+ Technology/Innovation
Jamie Barrand | Jan 6, 2016

Study of follicular lymphoma combination therapy shows promise

+ Regulatory
Jamie Barrand | Jan 6, 2016

Warren backs FDA change to blood donation policy

Jamie Barrand | Jan 6, 2016

Collaboration to support European efforts in autism research

+ Technology/Innovation
Jamie Barrand | Jan 6, 2016

American Heart Association staff lists top advances for 2015

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 480
  • 481
  • 482
  • 483
  • 484
  • 485
  • 486
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily